or Try an Advanced Search...

    Transcription Factors Stocks List

    Symbol Grade Name % Change
    IKNA F Ikena Oncology, Inc. 2.14
    IVA D Inventiva S.A. 3.88
    KRON F Kronos Bio, Inc. 3.89
    MBRX F Moleculin Biotech, Inc. 0.99
    RPHM D Reneo Pharmaceuticals, Inc. 5.42
    SGMO D Sangamo BioSciences, Inc. 6.72
    ZNTL F Zentalis Pharmaceuticals, Inc. 0.92
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Transcription Transcription Factor Biology Cancer Acute Myeloid Leukemia Biopharmaceutical Blastoma Glioblastoma Intracellular Receptors Novel Cancer Oncology Stage Pharmaceutical Alcohol Antiestrogens Antineoplastic Drugs Biotechnology Breast Cancer Cancer Therapeutics Cancer Therapies Carboxylic Acids

    Related ETFs - A few ETFs which own one or more of the above listed Transcription Factors stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 1.16
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.66
    SBIO C ALPS Medical Breakthroughs ETF 0.61
    LABD F Direxion Daily S&P Biotech Bear 3X Shares 0.48
    XBI C SPDR S&P Biotech ETF 0.44
    View all Transcription Factors ETFs...
    Compare ETFs
    Compare CNCR to BBC Compare SBIO to LABD Compare SBIO to XBI

        Transcription Factors Stocks Recent News

        Date Stock Title
        May 17 IVA Inventiva receives positive recommendation from DMC for late stage trial of NASH treatment
        May 17 RPHM Reneo Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying
        May 16 IVA Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
        May 16 KRON Down -5.63% in 4 Weeks, Here's Why Kronos Bio (KRON) Looks Ripe for a Turnaround
        May 14 IKNA Ikena Oncology reports Q1 GAAP EPS of -$0.33
        May 14 ZNTL Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
        May 13 IKNA Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
        May 13 IVA Why Is Inventiva's Stock Trading Higher on Monday?
        May 13 RPHM Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise
        May 13 RPHM Reneo Pharmaceuticals gains on deal to merge with OnKure
        May 13 RPHM Reneo Pharmaceuticals and OnKure Announce Proposed Merger
        May 13 IVA Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase IIb clinical trial demonstrating improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranor
        May 12 SGMO US$3.50 - That's What Analysts Think Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Is Worth After These Results
        May 12 SGMO Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript
        May 11 SGMO Sangamo Therapeutics First Quarter 2024 Earnings: US$0.27 loss per share (vs US$0.13 profit in 1Q 2023)
        Related Industries: Biotechnology
        Related Stock Lists: Transcription Transcription Factor Biology Cancer Acute Myeloid Leukemia Biopharmaceutical Blastoma Glioblastoma Intracellular Receptors Novel Cancer Oncology Stage Pharmaceutical Alcohol Antiestrogens Antineoplastic Drugs Biotechnology Breast Cancer Cancer Therapeutics Cancer Therapies Carboxylic Acids
        Transcription Factors

        Transcription factors are proteins that bind to specific DNA sequences and regulate the expression of genes. They are involved in the process of transcription, which is the first step in gene expression. Transcription factors can either activate or repress gene expression, depending on the type of transcription factor and the context in which it is acting.

        Browse All Tags